Josh Cosman, PhD, is an interdisciplinary neuroscientist with 20 years of experience developing neurophysiological and behavioral markers of cognition and motor function in healthy aging and neurological disorders. For the past decade his work has focused on supporting therapeutic development in both the digital health and pharmaceutical industries, leading development of translational biomarkers and novel functional markers using scalable research-grade tools and consumer devices. He is actively involved in several precompetitive initiatives in both the digital health and translational neuroscience domains, including serving as industry co-director or the Critical Path for Parkinson’s ‘Digital Drug Development Tools’ consortium.